Literature DB >> 16614723

PI3-kinase subunits are infrequent somatic targets in melanoma.

John A Curtin, Mitchell S Stark, Daniel Pinkel, Nicholas K Hayward, Boris C Bastian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16614723     DOI： 10.1038/sj.jid.5700311

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  28 in total

Review 1.  Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment.

Authors:  Thomas F Gajewski; Mercedes Fuertes; Robbert Spaapen; Yan Zheng; Justin Kline
Journal:  Curr Opin Immunol       Date:  2010-12-23       Impact factor: 7.486

Review 2.  Molecular targets in melanoma: time for 'ethnic personalization'.

Authors:  Shane Y Morita; Svetomir N Markovic
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 3.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

4.  Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.

Authors:  Carol Beadling; Michael C Heinrich; Andrea Warrick; Erin M Forbes; Dylan Nelson; Emily Justusson; Judith Levine; Tanaya L Neff; Janice Patterson; Ajia Presnell; Arin McKinley; Laura J Winter; Christie Dewey; Amy Harlow; Oscar Barney; Brian J Druker; Kathryn G Schuff; Christopher L Corless
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

5.  Melanoma: Molecular Pathogenesis and Therapeutic Management.

Authors:  Yuxin Liu; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2014

Review 6.  Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.

Authors:  Yunyi Kong; Suresh M Kumar; Xiaowei Xu
Journal:  Arch Pathol Lab Med       Date:  2010-12       Impact factor: 5.534

7.  Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.

Authors:  Michael A Davies; Katherine Stemke-Hale; E Lin; Carmen Tellez; Wanleng Deng; Yennu N Gopal; Scott E Woodman; Tiffany C Calderone; Zhenlin Ju; Alexander J Lazar; Victor G Prieto; Kenneth Aldape; Gordon B Mills; Jeffrey E Gershenwald
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 8.  Targeting mutant NRAS signaling pathways in melanoma.

Authors:  Ha Linh Vu; Andrew E Aplin
Journal:  Pharmacol Res       Date:  2016-03-15       Impact factor: 7.658

9.  A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.

Authors:  Elise Bonvin; Paola Falletta; Heather Shaw; Veronique Delmas; Colin R Goding
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

Review 10.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.